Document
type: Class

Anualidad
type: Class

Information Content Entity
type: Class

Conference Poster
type: Class

Continuant
type: Class

Entity
type: Class

2024
type: Class

Congress communication
type: Class

Generically Dependent Continuant
type: Class

individual
type: Document
rights: termsOfUse
date: 2026-08-31T21:39:18
publisher: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort
label: RDF description of Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort - http://research.umh.es/vivo/pub/comunicacion/270660

Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort
type: Document
related by: AutorExt:433979_2024-Comunicación:270660
related by: AutorExt:433961_2024-Comunicación:270660
ARG_2000028: 270660 vcard
related by: AutorExt:433935_2024-Comunicación:270660
related by: AutorExt:433949_2024-Comunicación:270660
related by: AutorExt:433933_2024-Comunicación:270660
type: 2024
related by: AutorExt:433932_2024-Comunicación:270660
related by: AutorExt:433952_2024-Comunicación:270660
type: Entity
most specific type: Conference Poster
related by: AutorExt:433931_2024-Comunicación:270660
related by: AutorExt:433938_2024-Comunicación:270660
related by: AutorExt:433962_2024-Comunicación:270660
related by: AutorExt:433947_2024-Comunicación:270660
RO_0002353: HIV DRUG THERAPY GLASGOW 2024
related by: AutorExt:433934_2024-Comunicación:270660
related by: AutorExt:433929_2024-Comunicación:270660
related by: AutorExt:433958_2024-Comunicación:270660
related by: AutorExt:433936_2024-Comunicación:270660
related by: AutorExt:433951_2024-Comunicación:270660
related by: AutorExt:433930_2024-Comunicación:270660
type: Anualidad
type: Information Content Entity
related by: Autor:227454-Comunicación:270660
related by: AutorExt:433957_2024-Comunicación:270660
related by: AutorExt:433960_2024-Comunicación:270660
type: Continuant
related by: AutorExt:433937_2024-Comunicación:270660
type: Conference Poster
related by: AutorExt:433953_2024-Comunicación:270660
related by: AutorExt:433950_2024-Comunicación:270660
related by: AutorExt:433948_2024-Comunicación:270660
related by: AutorExt:433955_2024-Comunicación:270660
most specific type: Congress communication
included: Medicina Clínica 2024
type: Congress communication
type: Thing
date time value: 270660 pubdate
related by: AutorExt:433959_2024-Comunicación:270660
related by: AutorExt:433963_2024-Comunicación:270660
most specific type: 2024
related by: AutorExt:433981_2024-Comunicación:270660
related by: AutorExt:433946_2024-Comunicación:270660
related by: Autor:215912-Comunicación:270660
related by: AutorExt:433980_2024-Comunicación:270660
type: Generically Dependent Continuant
related by: AutorExt:433956_2024-Comunicación:270660
related by: AutorExt:433964_2024-Comunicación:270660

AutorExt:433979_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433961_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433935_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433949_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433933_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433932_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433952_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433931_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433938_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433962_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433947_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

HIV DRUG THERAPY GLASGOW 2024
type: Conference
RO_0002234: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort
type: Entity
type: Anualidad
type: BFO_0000015
type: 2024
type: Event
type: Thing
type: BFO_0000003

AutorExt:433934_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433929_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433958_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433936_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433951_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433930_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

Autor:227454-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433957_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433960_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433937_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433953_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433950_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433948_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433955_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

Medicina Clínica 2024
type: Anualidad
type: 2024
type: DepartmentReport
type: Thing
type: ResearchReport
includes: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433959_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433963_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433981_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433946_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

Autor:215912-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433980_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433956_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort

AutorExt:433964_2024-Comunicación:270660
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Authorship
type: Continuant
relates: Switching to long acting intramuscular cabotegravir and rilpivirine in virologically suppressed PLHIV treated with dolutegravir/rilpivirine. A substudy from the RELATIVITY cohort